Cardiovascular risk doesn’t look the same for every patient, and the approach to managing it shouldn’t either. We’re sharing data at #NLASessions 2026 to advance how lipid management and cardiovascular risk are being understood and addressed.
Learn more: ir.newamsterdampharma.com/news-release...
Learn more: ir.newamsterdampharma.com/news-release...
June 10, 2026 at 6:31 PM
Cardiovascular risk doesn’t look the same for every patient, and the approach to managing it shouldn’t either. We’re sharing data at #NLASessions 2026 to advance how lipid management and cardiovascular risk are being understood and addressed.
Learn more: ir.newamsterdampharma.com/news-release...
Learn more: ir.newamsterdampharma.com/news-release...
Find us Friday, June 12 starting at 6:45 AM CT at the Sheraton Chicago Ballroom in Sections VIII-X; Fourth Floor during #NLASessions for this #CE symposium!
More info: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
More info: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
June 9, 2026 at 6:14 PM
Find us Friday, June 12 starting at 6:45 AM CT at the Sheraton Chicago Ballroom in Sections VIII-X; Fourth Floor during #NLASessions for this #CE symposium!
More info: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
More info: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
During the 2026 #NLASessions Opening Session CE Symposium, expert faculty will share practical strategies improved risk assessment, established target thresholds for treatment, and earlier intervention.
Register now: https://ow.ly/Ptw650YYjkQ
@nationallipid.bsky.social
Register now: https://ow.ly/Ptw650YYjkQ
@nationallipid.bsky.social
June 7, 2026 at 1:03 PM
During the 2026 #NLASessions Opening Session CE Symposium, expert faculty will share practical strategies improved risk assessment, established target thresholds for treatment, and earlier intervention.
Register now: https://ow.ly/Ptw650YYjkQ
@nationallipid.bsky.social
Register now: https://ow.ly/Ptw650YYjkQ
@nationallipid.bsky.social
This interactive program is designed for physicians, nurses and pharmacists involved in the management of patients with dyslipidemia.
Register now to attend at #NLASessions: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
Register now to attend at #NLASessions: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
June 6, 2026 at 2:01 PM
This interactive program is designed for physicians, nurses and pharmacists involved in the management of patients with dyslipidemia.
Register now to attend at #NLASessions: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
Register now to attend at #NLASessions: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
You won't want to miss the Opening Session CE Symposium at the 2026 #NLASessions!
For more information and to register, visit this link: https://events.vindicocme.com/15kYU86/5a2BUm31MKv?utm_source=bluesky&utm_medium=Post&utm_campaign=H703
@nationallipid.bsky.social
For more information and to register, visit this link: https://events.vindicocme.com/15kYU86/5a2BUm31MKv?utm_source=bluesky&utm_medium=Post&utm_campaign=H703
@nationallipid.bsky.social
June 2, 2026 at 6:01 PM
You won't want to miss the Opening Session CE Symposium at the 2026 #NLASessions!
For more information and to register, visit this link: https://events.vindicocme.com/15kYU86/5a2BUm31MKv?utm_source=bluesky&utm_medium=Post&utm_campaign=H703
@nationallipid.bsky.social
For more information and to register, visit this link: https://events.vindicocme.com/15kYU86/5a2BUm31MKv?utm_source=bluesky&utm_medium=Post&utm_campaign=H703
@nationallipid.bsky.social
Are you ready for the CME Situation Room? Hear insights to apply in your real-world scenarios during this program at #NLASessions.
Register now to join us in Chicago: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
Register now to join us in Chicago: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
June 1, 2026 at 6:01 PM
Are you ready for the CME Situation Room? Hear insights to apply in your real-world scenarios during this program at #NLASessions.
Register now to join us in Chicago: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
Register now to join us in Chicago: https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
During this live, case-based symposium at #NLASessions, you will review key recommendations for primary and secondary prevention of ASCVD.
Register today to join in person >> https://ow.ly/Ptw650YYjkQ
@nationallipid.bsky.social
Register today to join in person >> https://ow.ly/Ptw650YYjkQ
@nationallipid.bsky.social
May 26, 2026 at 7:30 PM
During this live, case-based symposium at #NLASessions, you will review key recommendations for primary and secondary prevention of ASCVD.
Register today to join in person >> https://ow.ly/Ptw650YYjkQ
@nationallipid.bsky.social
Register today to join in person >> https://ow.ly/Ptw650YYjkQ
@nationallipid.bsky.social
Join expert faculty on June 12 for this #CE symposium during #NLASessions in Chicago >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
@nationallipid.bsky.social @erinmichos.bsky.social
May 25, 2026 at 1:30 PM
Join expert faculty on June 12 for this #CE symposium during #NLASessions in Chicago >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
@nationallipid.bsky.social @erinmichos.bsky.social
Register today to attend the Opening Session CE Symposium at #NLASessions: "Lower for Longer: Lipid Management in an Era of Evolving Evidence" >> https://events.vindicocme.com/15kYU86/5a2BUm31MKv?utm_source=bluesky&utm_medium=Post&utm_campaign=H703
@nationallipid.bsky.social
@nationallipid.bsky.social
May 20, 2026 at 12:01 PM
Register today to attend the Opening Session CE Symposium at #NLASessions: "Lower for Longer: Lipid Management in an Era of Evolving Evidence" >> https://events.vindicocme.com/15kYU86/5a2BUm31MKv?utm_source=bluesky&utm_medium=Post&utm_campaign=H703
@nationallipid.bsky.social
@nationallipid.bsky.social
Join us at #NLASessions in Chicago. You will explore the latest evidence on CETP inhibition as an emerging treatment approach for patients with dyslipidemia.
Register today to join in person >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
Register today to join in person >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
May 18, 2026 at 11:30 AM
Join us at #NLASessions in Chicago. You will explore the latest evidence on CETP inhibition as an emerging treatment approach for patients with dyslipidemia.
Register today to join in person >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
Register today to join in person >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
Kick off the 2026 #NLASessions with this Opening Session CE Symposium!
Registration and more information can be found here: https://events.vindicocme.com/15kYU86/5a2BUm31MKv?utm_source=bluesky&utm_medium=Post&utm_campaign=H703
@nationallipid.bsky.social
Registration and more information can be found here: https://events.vindicocme.com/15kYU86/5a2BUm31MKv?utm_source=bluesky&utm_medium=Post&utm_campaign=H703
@nationallipid.bsky.social
May 14, 2026 at 3:30 PM
Kick off the 2026 #NLASessions with this Opening Session CE Symposium!
Registration and more information can be found here: https://events.vindicocme.com/15kYU86/5a2BUm31MKv?utm_source=bluesky&utm_medium=Post&utm_campaign=H703
@nationallipid.bsky.social
Registration and more information can be found here: https://events.vindicocme.com/15kYU86/5a2BUm31MKv?utm_source=bluesky&utm_medium=Post&utm_campaign=H703
@nationallipid.bsky.social
Step into the CME Situation Room at #NLASessions on 6/12!
Registration is now open to attend in Chicago >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
Registration is now open to attend in Chicago >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
May 10, 2026 at 9:01 PM
Step into the CME Situation Room at #NLASessions on 6/12!
Registration is now open to attend in Chicago >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
Registration is now open to attend in Chicago >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
Attending #NLASessions in Chicago? Join us Friday, 6/12 for this #CE symposium: "CME Situation Room: Exploring the Cardiovascular and Neurocognitive Implications of CETP Inhibition" >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
@nationallipid.bsky.social @erinmichos.bsky.social
May 5, 2026 at 1:05 PM
Attending #NLASessions in Chicago? Join us Friday, 6/12 for this #CE symposium: "CME Situation Room: Exploring the Cardiovascular and Neurocognitive Implications of CETP Inhibition" >> https://ow.ly/sOxL50YRGQa
@nationallipid.bsky.social @erinmichos.bsky.social
@nationallipid.bsky.social @erinmichos.bsky.social
We're in the FINAL hours!⌛
Only 12 hours left to submit your #NLASessions abstract. Submissions close TONIGHT at 11:59 PM ET. No extensions!
Submit now👉 lipid.org/abstracts
Only 12 hours left to submit your #NLASessions abstract. Submissions close TONIGHT at 11:59 PM ET. No extensions!
Submit now👉 lipid.org/abstracts
January 12, 2026 at 5:00 PM
We're in the FINAL hours!⌛
Only 12 hours left to submit your #NLASessions abstract. Submissions close TONIGHT at 11:59 PM ET. No extensions!
Submit now👉 lipid.org/abstracts
Only 12 hours left to submit your #NLASessions abstract. Submissions close TONIGHT at 11:59 PM ET. No extensions!
Submit now👉 lipid.org/abstracts
Final weekend reminder!⏰
This is the last chance to work on and submit your #NLASessions abstract. Take advantage of the extension and make sure your research is part of lipidology’s premier scientific meeting.
The deadline is Monday — don’t wait.
👉Submit now: lipid.org/lipidinsights
This is the last chance to work on and submit your #NLASessions abstract. Take advantage of the extension and make sure your research is part of lipidology’s premier scientific meeting.
The deadline is Monday — don’t wait.
👉Submit now: lipid.org/lipidinsights
January 9, 2026 at 4:01 PM
Final weekend reminder!⏰
This is the last chance to work on and submit your #NLASessions abstract. Take advantage of the extension and make sure your research is part of lipidology’s premier scientific meeting.
The deadline is Monday — don’t wait.
👉Submit now: lipid.org/lipidinsights
This is the last chance to work on and submit your #NLASessions abstract. Take advantage of the extension and make sure your research is part of lipidology’s premier scientific meeting.
The deadline is Monday — don’t wait.
👉Submit now: lipid.org/lipidinsights
🚨Deadline Extended!🚨
You now have until January 12 at 11:59 PM ET to submit your abstract for the 2026 #NLASessions. Take advantage of this extension and make sure your research is part of the premier meeting in lipidology!
🔗Submit now: lipid.org/abstracts
You now have until January 12 at 11:59 PM ET to submit your abstract for the 2026 #NLASessions. Take advantage of this extension and make sure your research is part of the premier meeting in lipidology!
🔗Submit now: lipid.org/abstracts
January 5, 2026 at 7:42 PM
🚨Deadline Extended!🚨
You now have until January 12 at 11:59 PM ET to submit your abstract for the 2026 #NLASessions. Take advantage of this extension and make sure your research is part of the premier meeting in lipidology!
🔗Submit now: lipid.org/abstracts
You now have until January 12 at 11:59 PM ET to submit your abstract for the 2026 #NLASessions. Take advantage of this extension and make sure your research is part of the premier meeting in lipidology!
🔗Submit now: lipid.org/abstracts
Abstracts for the 2026 #NLASessions are due in ONE WEEK!⏳
If you have lipidology research to share, THIS is your moment. Don’t miss the chance to showcase your work and be part of the science shaping the future of lipid care.
Submission portal👉lipid.org/abstracts
If you have lipidology research to share, THIS is your moment. Don’t miss the chance to showcase your work and be part of the science shaping the future of lipid care.
Submission portal👉lipid.org/abstracts
December 29, 2025 at 10:00 PM
Abstracts for the 2026 #NLASessions are due in ONE WEEK!⏳
If you have lipidology research to share, THIS is your moment. Don’t miss the chance to showcase your work and be part of the science shaping the future of lipid care.
Submission portal👉lipid.org/abstracts
If you have lipidology research to share, THIS is your moment. Don’t miss the chance to showcase your work and be part of the science shaping the future of lipid care.
Submission portal👉lipid.org/abstracts
Submit your abstract for the 2026 #NLASessions and be part of the science shaping lipidology!
Accepted abstracts will be featured in the #NLASessions Poster Hall and published in the Journal of Clinical Lipidology.
Two weeks left to submit! Don't wait👉lipid.org/abstracts
Accepted abstracts will be featured in the #NLASessions Poster Hall and published in the Journal of Clinical Lipidology.
Two weeks left to submit! Don't wait👉lipid.org/abstracts
December 22, 2025 at 10:00 PM
Submit your abstract for the 2026 #NLASessions and be part of the science shaping lipidology!
Accepted abstracts will be featured in the #NLASessions Poster Hall and published in the Journal of Clinical Lipidology.
Two weeks left to submit! Don't wait👉lipid.org/abstracts
Accepted abstracts will be featured in the #NLASessions Poster Hall and published in the Journal of Clinical Lipidology.
Two weeks left to submit! Don't wait👉lipid.org/abstracts
For those inquisitive about obicetrapib,
Archna Bajaj report a kinetic lipoprotein study which provides insight on how the med significantly reduces apoB. x.com/nationallipi... @aspcardio.bsky.social @escardio.bsky.social @familyheartfdn.bsky.social
Archna Bajaj report a kinetic lipoprotein study which provides insight on how the med significantly reduces apoB. x.com/nationallipi... @aspcardio.bsky.social @escardio.bsky.social @familyheartfdn.bsky.social
National Lipid Association on X: "How does Obicetrapib lower LDL-C?🔬 At #NLASessions, we asked @ArchnaBajajMD to break down her team's lipoprotein kinetic study and what it reveals about the drug's mechanism. Watch the video to learn more! #ClinicalTrial #LDLCholesterol #PennMedicine #Research https://t.co/wS3nd3iecp" / X
How does Obicetrapib lower LDL-C?🔬 At #NLASessions, we asked @ArchnaBajajMD to break down her team's lipoprotein kinetic study and what it reveals about the drug's mechanism. Watch the video to learn more! #ClinicalTrial #LDLCholesterol #PennMedicine #Research https://t.co/wS3nd3iecp
x.com
June 19, 2025 at 12:42 PM
For those inquisitive about obicetrapib,
Archna Bajaj report a kinetic lipoprotein study which provides insight on how the med significantly reduces apoB. x.com/nationallipi... @aspcardio.bsky.social @escardio.bsky.social @familyheartfdn.bsky.social
Archna Bajaj report a kinetic lipoprotein study which provides insight on how the med significantly reduces apoB. x.com/nationallipi... @aspcardio.bsky.social @escardio.bsky.social @familyheartfdn.bsky.social
@nationallipid.bsky.social #NLASessions Dr Kalra discussing his trial of usual care versus very high intensity lipid lowering based on plaque Alaysis—ARTCAP TRIAL
June 4, 2025 at 9:40 PM
@nationallipid.bsky.social #NLASessions Dr Kalra discussing his trial of usual care versus very high intensity lipid lowering based on plaque Alaysis—ARTCAP TRIAL
📣In case you missed it at #NLASessions: The NLA released its Expert Clinical Review on Multidisciplinary Teams in Clinical Lipidology and Cardiometabolic Care.🩺🫀
Read the article & download the clinician infographic: ow.ly/poRE50W4smS
Read the article & download the clinician infographic: ow.ly/poRE50W4smS
June 4, 2025 at 8:51 PM
📣In case you missed it at #NLASessions: The NLA released its Expert Clinical Review on Multidisciplinary Teams in Clinical Lipidology and Cardiometabolic Care.🩺🫀
Read the article & download the clinician infographic: ow.ly/poRE50W4smS
Read the article & download the clinician infographic: ow.ly/poRE50W4smS
@nationallipid.bsky.social #NLASessions Coronary perivascular fat is a biomarker for CV risk
May 31, 2025 at 2:02 PM
@nationallipid.bsky.social #NLASessions Coronary perivascular fat is a biomarker for CV risk
We’re excited to see data from our Phase 3 BROADWAY study shared in a late-breaking oral presentation at #NLASessions. Discover what we’ve learned in this study of 2,500 patients at high risk for cardiovascular disease. www.newamsterdampharma.com/wp-content/u...
May 30, 2025 at 5:16 PM
We’re excited to see data from our Phase 3 BROADWAY study shared in a late-breaking oral presentation at #NLASessions. Discover what we’ve learned in this study of 2,500 patients at high risk for cardiovascular disease. www.newamsterdampharma.com/wp-content/u...
A pooled analysis from three of our Phase 3 studies evaluated obicetrapib’s effect on Lp(a) in people at increased risk for cardiovascular disease, particularly in those with baseline Lp(a) from 50-150 nmo/L. See the data shared at #NLASessions: www.newamsterdampharma.com/wp-content/u...
May 30, 2025 at 3:32 PM
A pooled analysis from three of our Phase 3 studies evaluated obicetrapib’s effect on Lp(a) in people at increased risk for cardiovascular disease, particularly in those with baseline Lp(a) from 50-150 nmo/L. See the data shared at #NLASessions: www.newamsterdampharma.com/wp-content/u...
@nationallipid.bsky.social #NLASessions DrRay teaching us about CTEP inhibition
May 30, 2025 at 12:30 PM
@nationallipid.bsky.social #NLASessions DrRay teaching us about CTEP inhibition